Stock Price
718.60
Daily Change
5.00 0.70%
Monthly
5.12%
Yearly
13.81%
Q1 Forecast
686.63

argenx SE reported $7.18B in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
AstraZeneca USD 114.46B 2.03B Sep/2025
Galapagos EUR 3.51B 306.31M Sep/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
GRIFOLS EUR 19.85B 86.61M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Qiagen NV USD 6.55B 729.74M Sep/2025
UCB EUR 17.35B 1.72B Dec/2024